An international research team has innovatively converted ordinary beer yeast into a "micro luminescent drug factory," capable of swiftly generating and evaluating billions of peptide-based compounds. This groundbreaking approach harnesses the power of brewer's yeast to synthesize unique peptide compounds that hold promising therapeutic potential, heralding the acceleration of the development of safer and more targeted medications.